Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Guardion Health Sciences launches online store for Viactiv » 08:34
01/24/22
01/24
08:34
01/24/22
08:34
GHSI

Guardion Health Sciences

/

+

Guardion Health Sciences…

Guardion Health Sciences announced the launch of its new branded Shopify store for its Viactiv line of products, URL The new e-commerce venue offers Viactiv customers an omni-channel experience, allowing them to shop via retail outlets or online either through those same retail websites or directly through the Company itself in its new branded website. The store features all of Viactiv's current product line, including newly launched Calcium+Immune, which features high potency levels of Vitamin D3 and zinc to support and boost the immune system. The site also features legacy products, Calcium+Bone Strengthening and Calcium+Bone Strengthening. In addition, the new e-store features a "Learn" section, which offers nutrition tips, ingredient information, and a deeper dive into the custom-designed clinical benefits supporting the Viactiv line.

ShowHide Related Items >><<
GHSI Guardion Health Sciences
/

+

GHSI Guardion Health Sciences
/

+

Over a month ago
Hot Stocks
Guardion Health Sciences to wind down VectorVision business » 16:06
12/23/21
12/23
16:06
12/23/21
16:06
GHSI

Guardion Health Sciences

/

+

Guardion Health…

Guardion Health "announced that, as part of its ongoing comprehensive evaluation of its business, it will wind down the business operations of its VectorVision business and, instead, focus on exploiting its valuable intellectual property and technology using a restructured and more cost-efficient approach. The company is exploring both domestic and international business opportunities, such as licensing and distribution arrangements, with qualified parties, to assist the company in the economic exploitation of these intellectual property rights, including the VectorVision patents. As a result of this change to the VectorVision business strategy, management believes that it will be able to better focus its efforts and deploy capital to more growth-oriented brands and product lines, such as Viactiv, and other products in development, that it hopes to expeditiously bring to market in 2022. The company expects the wind-down to be completed by approximately March 31, 2022."

ShowHide Related Items >><<
GHSI Guardion Health Sciences
/

+

GHSI Guardion Health Sciences
/

+

Hot Stocks
Guardion Health Sciences 'seeking opportunities to utilize' M&A » 08:13
12/16/21
12/16
08:13
12/16/21
08:13
GHSI

Guardion Health Sciences

/

+

Guardion Health Sciences…

Guardion Health Sciences issued a letter to Shareholders, which read in part: "During the course of the past year, we have been working non-stop toward re-creating your company into becoming a premier provider of clinically proven, trusted health and wellness products. I feel like it is safe to say that the Guardion that began 2021 is not the same Guardion finishing the year 2021, and that we are optimistic regarding our future in 2022 and beyond. Our transformation effectively began mid-year with the acquisition of the Viactiv brand in June, which has significantly altered our product mix, revenue stream and organic growth potential. Since then, our focus has been on growing those revenues through improved and enhanced business and marketing practices, as well as optimizing our results from our existing business through improved internal financial management tools and aggressively seeking and evaluating opportunities to expand our market share. We have regularly communicated our confidence that exploitation of the Viactiv brand will be the cornerstone of our future success...In addition to the commercialization and business development activities described above, we are regularly seeking opportunities to utilize mergers and acquisitions and similar transactions to advance the Company's business strategy and provide immediate opportunities to rapidly scale our business. Targets that would advance Guardion's business strategy and focus include companies with an established brand presence, growing revenues, strong distribution channels and/or profitable sales, commercialized products that could strengthen our product portfolio, and products that present strong growth opportunities and unique science or technology profiles. Finally, the Guardion management team is looking forward to increasing the frequency of shareholder communications to be able to report on achieving measurable and tangible milestones as part of the Company's overall long-term progress. Over the long-term, I believe that Guardion's success will depend on our ability to create value in well-differentiated and robust brands comprised of strong clinically proven products that address consumer needs in growing markets. We are committed to bringing compelling products to market under meaningful and differentiated brands that are supported by strong science. The activities in 2021 allow us to be in a much better position to create value for our shareholders primarily as a result of the Viactiv acquisition. We also recognize that we have much to accomplish in 2022 and beyond and management and the Board are committed to doing the hard work necessary to benefit our shareholders. We are looking forward to continuing to execute on the plans outlined above, and to sharing the incremental progress of many of those activities, through additional shareholder communications. In the meantime, we wish all of our shareholders a prosperous, safe and healthy holiday season and look forward to a strong 2022."

ShowHide Related Items >><<
GHSI Guardion Health Sciences
/

+

GHSI Guardion Health Sciences
/

+

Hot Stocks
Guardion Health Sciences appoints Michaela Griggs to board of directors » 08:39
12/09/21
12/09
08:39
12/09/21
08:39
GHSI

Guardion Health Sciences

$1.03 /

+0.03 (+3.00%)

Guardion Health Sciences…

Guardion Health Sciences announced today that Michaela Griggs, a seasoned healthcare executive, has been appointed to its Board of Directors. Griggs currently serves as Chief Executive Officer of Los Angeles-based Southern California Reproductive Center.

ShowHide Related Items >><<
GHSI Guardion Health Sciences
$1.03 /

+0.03 (+3.00%)

GHSI Guardion Health Sciences
$1.03 /

+0.03 (+3.00%)

Conference/Events
Guardion Health Sciences participates in a conference call with Maxim » 04:55
11/30/21
11/30
04:55
11/30/21
04:55
GHSI

Guardion Health Sciences

$1.04 /

-0.095 (-8.41%)

Conference call with…

Conference call with President & CEO Scholtes on November 30 hosted by Maxim.

ShowHide Related Items >><<
GHSI Guardion Health Sciences
$1.04 /

-0.095 (-8.41%)

GHSI Guardion Health Sciences
$1.04 /

-0.095 (-8.41%)

Conference/Events
Guardion Health Sciences participates in a conference call with MKM Partners » 12:06
11/22/21
11/22
12:06
11/22/21
12:06
GHSI

Guardion Health Sciences

$1.07 /

-0.01 (-0.93%)

Conference call with…

Conference call with President & CEO Scholtes on November 30 hosted by MKM Partners.

ShowHide Related Items >><<
GHSI Guardion Health Sciences
$1.07 /

-0.01 (-0.93%)

GHSI Guardion Health Sciences
$1.07 /

-0.01 (-0.93%)

Earnings
Guardion Health Sciences reports Q3 EPS (12c) vs (15c) last year » 08:41
11/10/21
11/10
08:41
11/10/21
08:41
GHSI

Guardion Health Sciences

$1.38 /

-0.02 (-1.43%)

Reports Q3 revenue…

Reports Q3 revenue $3.148M vs $253,000 last year. Bret Scholtes, Guardion's President and Chief Executive Officer, commented, "We are encouraged by our third quarter results, which demonstrated measurable progress towards our goal of building a leading clinical nutrition company. Our revenue growth, driven by the performance of the recently acquired Viactiv product line, represents the highest quarterly sales results in Guardion's history. We achieved these results despite the challenging supply chain environment, and our management team is actively focusing on supply chain matters given industry-wide constraints. In addition, the Viactiv brand has been completely and successfully integrated into our business, and we remain confident in our ability to drive organic growth through expansion of the Viactiv brand. Our focus is now shifting to ways that we can successfully leverage the established distribution channels and brand awareness of Viactiv to accelerate the growth of the Company into a leader in clinical nutrition."

ShowHide Related Items >><<
GHSI Guardion Health Sciences
$1.38 /

-0.02 (-1.43%)

GHSI Guardion Health Sciences
$1.38 /

-0.02 (-1.43%)

Over a quarter ago
Hot Stocks
Guardion Health Sciences announces two key initiatives » 08:07
10/14/21
10/14
08:07
10/14/21
08:07
GHSI

Guardion Health Sciences

$1.03 /

-0.005 (-0.48%)

Guardion Health Sciences…

Guardion Health Sciences announces two key initiatives designed to both improve the customer experience and engagement, as well as to reduce costs throughout the Company. Guardion has entered into an agreement to terminate the lease on its San Diego, California corporate office and main warehouse facility, which was utilized primarily for the Company's ocular products business. This agreement will take effect at the end of October and is expected to reduce Guardion's overhead costs. Guardion is currently in the process of moving its product inventory to a third-party logistics provider. In addition, the Company has launched a new and improved corporate and investor website to better engage with its investors, customers and other stakeholders. "We continue to evaluate our current activities and how we can maximize customer engagement and increase sales, with a particular focus on the recently-acquired Viactiv business, while also carefully and prudently managing our cost structure, in order to create optimal shareholder value," said Bret Scholtes, Guardion's CEO. "By addressing these fundamental issues, we will continue our efforts to move Guardion towards becoming a key player in the clinical nutrition market."

ShowHide Related Items >><<
GHSI Guardion Health Sciences
$1.03 /

-0.005 (-0.48%)

GHSI Guardion Health Sciences
$1.03 /

-0.005 (-0.48%)

Earnings
Guardion Health Sciences reports Q2 EPS (19c) vs. (5c) last year » 08:53
08/16/21
08/16
08:53
08/16/21
08:53
GHSI

Guardion Health Sciences

$1.24 /

-0.06 (-4.62%)

Reports Q2 revenue $1.22M…

Reports Q2 revenue $1.22M vs. $1.19M last year. Bret Scholtes, Guardion's President and Chief Executive Officer, commented, "The three months ended June 30, 2021 marks the beginning of a new era for Guardion, as the acquisition and integration of the Viactiv line of products has changed the Company's financial position, market profile and brand focus, and has also expanded the Company's search for additional business opportunities in the short-term, both internal and external."

ShowHide Related Items >><<
GHSI Guardion Health Sciences
$1.24 /

-0.06 (-4.62%)

GHSI Guardion Health Sciences
$1.24 /

-0.06 (-4.62%)

Hot Stocks
Sientra appoints Andy Schmidt as Chief Financial Officer » 08:19
07/12/21
07/12
08:19
07/12/21
08:19
SIEN

Sientra

$8.41 /

+0.305 (+3.77%)

, GHSI

Guardion Health Sciences

$1.57 /

+0.025 (+1.62%)

Sientra (SIEN) announced…

Sientra (SIEN) announced that Andy Schmidt has been appointed Chief Financial Officer effective immediately. As a key member of Sientra's executive leadership team, Schmidt will lead the company's financial operations. Schmidt brings to Sientra more than 20 years of financial leadership experience and has successfully directed the financial, M & A and capital market strategies of numerous publicly held companies. Most recently, he served as the CFO of Guardion Health Sciences (GHSI).

ShowHide Related Items >><<
SIEN Sientra
$8.41 /

+0.305 (+3.77%)

GHSI Guardion Health Sciences
$1.57 /

+0.025 (+1.62%)

SIEN Sientra
$8.41 /

+0.305 (+3.77%)

02/05/21 Canaccord
Sientra price target raised to $8 from $6 at Canaccord
10/08/20 Stifel
Stifel sees upside potential for Sientra after survey of aesthetics doctors
GHSI Guardion Health Sciences
$1.57 /

+0.025 (+1.62%)

SIEN Sientra
$8.41 /

+0.305 (+3.77%)

GHSI Guardion Health Sciences
$1.57 /

+0.025 (+1.62%)

  • 09
    Feb
SIEN Sientra
$8.41 /

+0.305 (+3.77%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.